GSK-205864

Study Sponsor: GSK

Study Title

A randomized, double-blind, Sponsor open, placebo-controlled, 52 week study evaluating the effect of danirixin (GSK1325756) on lung function and health related quality of life in participants with mild to moderate Chronic Obstructive Pulmonary Disease (COPD)

Medicine or Vaccine (generic name)

danirixin

Sponsor Identification Number

205864

Trial Registry Identification Number(#'s)

NCT03170232

Medical Condition

Pulmonary Disease, Chronic Obstructive

Phase

Phase 2

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=205864

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT03170232

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

June 2020